Skip to content

Multipharma

Active Cooperative companyfounded 2004active for 22 yearsMarie Curiesquare 30, 1070 AnderlechtKBO/BCE: BE 0866.855.346 subsidiary of #3 employer in the Brussels-Capital Region, Retail trade sector

Lifetime

19 annual accounts with figures on one time axis, 22 filings since 2005
peak of €580.8m in 2025
€580.8m▲ 5.7%
lowest -€50.8m in 2017
-€2.9m▼ €2.0m
peak of €128.1m in 2025
€128.1m▲ 33.8%
€141.7m▲ 60.5%
peak of 1,624.6 FTE in 2018
1,522.8 FTE▲ 1.1%
Board27 names since 2014all names
6 directors and 5 others
Owners4 names in the annual accounts
100%
Documentsfilings and deeds
14-10-202675 days late
2025financial year
Loss of €2.9mMerger: MULTIPHARMA takes over Farmannso 21-10Merger proposal: MULTIPHARMA takes over Farmannso 26-081 director appointed, 1 resignation, 3 reappointments, 1 stat… 03-07Merger: MULTIPHARMA takes over APOPLUS, ApoLierConsult, PHARM… 24-06Equity from €95.7m to €128.1m

Key points

from the 2025 annual accounts

Result

-€2.9m ▼ 249%
-€819,0002024-€2.9m2025

The result fell in 2025: merger with Farmannso.

Growth

6 years
20182019202020212022202320242025

6 years of growth in a row. Turnover of €580.8m in 2025.

Debts

€141.7m ▲ 60.5%
Financial debts
+37.0
Suppliers
+10.6
Other debts
+6.9
The rest
-1.1

Debts rose by €53.4m in 2025.

Filings

21 annual accounts 23 filings, 75 days
AprilJune31 JulyOctober20052010201520202025

Latest accounts filed late: after the legal deadline.

Position in the sector

-€2.9m

Lower net result than 95% of companies in retail trade. The sector median is €59,249, over 2,459 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 153 companies had the same profile as Multipharma has now. Each dot is one company, two years later.

94.1%
were still trading
3.9%
stopped another way
1.3%
went bankrupt
  • Large
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 153 companies, not a prediction for Multipharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director
Director
Director
Director
Auditor,
and 1 other
  • 100%score equity €164.7m (2025) · annual accounts 2025
  • consolidatesannual accounts 2025

Shares in 1 company,

Board & ownership

Recent changes

Environmental permit granted New advertising · decided by Leuven
Environmental permit granted Convert or extend · decided by Beringen
Environmental permit granted New advertising · decided by Aalst
Environmental permit granted New advertising · decided by Kuurne
All 170 events

Comparable companies

same main activity, similar in size and age
Company
Multipharma Anderlecht €580.8m 0.0% 46.7% 1,522.8
MEDI-MARKET Parapharmacies Evere €326.6m 1.5% 6.7% 319.1
L'Economie Populaire Ciney €172.9m 0.9% 13.0% 631.4
BENU Wavre €172.2m 0.6% 51.2% 370.2
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT Thimister-Clermont €109.5m 2.5% 32.5% 340.1
TILMAN Somme-Leuze €58.2m 7.5% 29.5% 212
COOP-APOTHEKEN Ghent €85.3m 1.1% 41.4% 227.1
-10%0%10%20%€100m€200m€500m€1bn€2bn€5bnMultipharmaEBIT margin

Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as Multipharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €31m and €171m, founded between 1913 and 2014.

Official details

Source: KBO
Status
Active since 19-08-2004Normal situation
Registered office
15 active companies are registered at this addressSource: KBO register, as of 19 November 2026.
Activity
Retail sale of pharmaceutical productsNACE 47730and 5 others
Joint committees
313Pharmacies and pricing offices
321Wholesale distributors of medicines · annual accounts 2024
Establishment units
2.004.068.4012800 Mechelen, since 01-10-1920
2.004.068.5972800 Mechelen, since 01-10-1920and 242 others
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

€274.3m▲ 45.5%
Employeeson 31-12-2025
1,682▲ 0.1%
Filing
Filed on 14-10-2026
Financials

Insights on Multipharma

Multipharma has existed since 2004. Turnover grew from €109,001 in 2015 to €580.8m in 2025 and staff from 0.6 to 1,522.8 full-time equivalents.

Turnover has grown every year since 2019.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Multipharma

What is the company number of Multipharma?
The company number of Multipharma is 0866.855.346. The VAT number is the same number with BE in front: BE 0866.855.346.
Where is Multipharma based?
The registered office is at Marie Curiesquare 30, 1070 Anderlecht.Company details
What does Multipharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Multipharma?
Multipharma is a cooperative company (CV).
When was Multipharma founded?
Multipharma was founded on 19-08-2004.
Is Multipharma still active?
Yes, Multipharma is an active enterprise in the KBO register.
How many employees does Multipharma have?
Multipharma had an average of 1,522.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Multipharma fall under?
In its 2024 annual accounts, Multipharma states joint committees 313 (Pharmacies and pricing offices) and 321 (Wholesale distributors of medicines).
What is the turnover of Multipharma?
The turnover of Multipharma was €580.8m in financial year 2025, according to the filed annual accounts.
Is Multipharma profitable?
In financial year 2025, Multipharma made a loss of €2.9m.
Where can I find the annual accounts of Multipharma?
Multipharma filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Multipharma due?
Multipharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.